TC
WST icon

TownSquare Capital’s West Pharmaceutical WST Stock Holding History

TownSquare Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-789
Closed -$207K – 381
2025
Q3 		$207K Sell
789
-1,621
-67% -$394K 0.03% 355
2025
Q2 		$527K Sell
2,410
-31,681
-93% -$6.77M 0.05% 329
2025
Q1 		$7.63M Buy
34,091
+3,841
+13% +$1.06M 0.08% 229
2024
Q4 		$9.91M Buy
30,250
+846
+3% +$266K 0.11% 169
2024
Q3 		$8.83M Buy
29,404
+879
+3% +$269K 0.11% 178
2024
Q2 		$9.4M Buy
28,525
+2,005
+8% +$709K 0.13% 149
2024
Q1 		$10.5M Buy
26,520
+2,295
+9% +$849K 0.15% 127
2023
Q4 		$8.53M Buy
24,225
+1,169
+5% +$414K 0.15% 134
2023
Q3 		$8.65M Sell
23,056
-842
-4% -$326K 0.16% 126
2023
Q2 		$9.14M Buy
23,898
+1,258
+6% +$449K 0.17% 121
2023
Q1 		$7.84M Buy
22,640
+1,492
+7% +$436K 0.17% 109
2022
Q4 		$4.98M Buy
21,148
+4,026
+24% +$954K 0.12% 162
2022
Q3 		$4.21M Buy
17,122
+1,091
+7% +$332K 0.12% 156
2022
Q2 		$4.85M Buy
16,031
+204
+1% +$66.4K 0.14% 137
2022
Q1 		$6.5M Sell
15,827
-383
-2% -$150K 0.17% 110
2021
Q4 		$7.6M Buy
16,210
+1,987
+14% +$855K 0.19% 95
2021
Q3 		$6.04M Buy
14,223
+3,524
+33% +$1.49M 0.17% 108
2021
Q2 		$3.95M Buy
10,699
+3,119
+41% +$1.03M 0.13% 142
2021
Q1 		$2.14M Buy
7,580
+1,031
+16% +$295K 0.08% 198
2020
Q4 		$1.86M Buy
6,549
+1,019
+18% +$286K 0.08% 197
2020
Q3 		$1.6M Buy
5,530
+2,285
+70% +$605K 0.09% 171
2020
Q2 		$743K Buy
+3,245
New +$638K 0.05% 234

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

TownSquare Capital's WST Position: Q4 2025 in Review

TownSquare Capital sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 789 shares — an estimated $207K sold.

TownSquare Capital first reported a position in WST in Q2 2020 and held it in 22 quarters. The position peaked at $10.5M in Q1 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • TownSquare Capital reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • TownSquare Capital sold 789 West Pharmaceutical shares in Q4 2025, an estimated $207K.
  • TownSquare Capital first reported a position in West Pharmaceutical in Q2 2020 and held it in 22 quarters.
  • TownSquare Capital's West Pharmaceutical position peaked at $10.5M in Q1 2024.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on TownSquare Capital's 13F filing for Q4 2025, filed 11 Feb 2026.